Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8808679
Auristatin compounds and conjugates thereof
granted -
US 8809400
Method to ameliorate oxidative stress and improve working memory via pterostilbene administration
granted -
US 8809292
Compositions and methods for inhibiting expression of the PCSK9 gene
granted -
US 8809515
Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
granted -
US 8809453
Branched polymers
granted -
US 8809516
Therapeutic compositions
granted -
US 8809293
Compositions and methods for inhibiting gene expression of hepatitis B virus
granted -
US 8809271
Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
granted -
US 8809291
Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma
granted -
US 8802844
Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis
granted -
US 8802836
Cloning and recombinant productions of Vespula venom protease and methods of use thereof
granted -
US 8802633
Autophagy-inducing peptide analogs
granted -
US 8802644
Lipid formulation
granted -
US 8802090
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
granted -
US 8802695
Apoptosis signal-regulating kinase 1 inhibitors
granted -
US 8802074
Polymers functionalized with ion-specific recognition elements
granted -
US 8802628
Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration
granted -
US 8802656
Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same
granted -
US 8802107
VEGF antagonist formulations for intravitreal administration
granted -
US 8802854
Crystalline forms of Prasugrel salts
granted -
US 8802773
In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
granted -
US 8802733
Aldehyde dehydrogenase inhibitors as novel depigmenting agents
granted -
US 8802699
Quinuclidine derivatives and medicinal compositions containing the same
granted -
US 8802698
8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.